In this issue:
Dabigatran and acute coronary event risk
DVT regression in immobile stroke patients
Low-dose rituximab in idiopathic AIHA
Long-term follow-up of PVT and MPNs
First thrombosis in high-risk aPL carriers
AAV8 vector-mediated gene transfer in haemophilia B
Reducing HIT risk: PF4 interactions with platelets
Adjuvant rituximab for nonsplenectomised ITP
ELN criteria for hydroxyurea in polycythaemia vera
Alemtuzumab in severe aplastic anaemia
Please login below to download this issue (PDF)